169 related articles for article (PubMed ID: 22645299)
1. The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress.
Klubo-Gwiezdzinska J; Jensen K; Bauer A; Patel A; Costello J; Burman KD; Wartofsky L; Hardwick MJ; Vasko VV
J Endocrinol; 2012 Aug; 214(2):207-16. PubMed ID: 22645299
[TBL] [Abstract][Full Text] [Related]
2. GABA receptor expression in benign and malignant thyroid tumors.
Roberts SS; Mendonça-Torres MC; Jensen K; Francis GL; Vasko V
Pathol Oncol Res; 2009 Dec; 15(4):645-50. PubMed ID: 19381877
[TBL] [Abstract][Full Text] [Related]
3. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
Shoukrun R; Veenman L; Shandalov Y; Leschiner S; Spanier I; Karry R; Katz Y; Weisinger G; Weizman A; Gavish M
Pharmacogenet Genomics; 2008 Nov; 18(11):977-88. PubMed ID: 18806692
[TBL] [Abstract][Full Text] [Related]
4. Translocator protein blockade reduces prostate tumor growth.
Fafalios A; Akhavan A; Parwani AV; Bies RR; McHugh KJ; Pflug BR
Clin Cancer Res; 2009 Oct; 15(19):6177-84. PubMed ID: 19789311
[TBL] [Abstract][Full Text] [Related]
5. Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling.
Yasin N; Veenman L; Singh S; Azrad M; Bode J; Vainshtein A; Caballero B; Marek I; Gavish M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387723
[TBL] [Abstract][Full Text] [Related]
6. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression.
Veenman L; Gavish M
Curr Mol Med; 2012 May; 12(4):398-412. PubMed ID: 22348610
[TBL] [Abstract][Full Text] [Related]
7. PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells.
Chelli B; Salvetti A; Da Pozzo E; Rechichi M; Spinetti F; Rossi L; Costa B; Lena A; Rainaldi G; Scatena F; Vanacore R; Gremigni V; Martini C
J Cell Biochem; 2008 Oct; 105(3):712-23. PubMed ID: 18668527
[TBL] [Abstract][Full Text] [Related]
8. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.
Zeno S; Zaaroor M; Leschiner S; Veenman L; Gavish M
Biochemistry; 2009 Jun; 48(21):4652-61. PubMed ID: 19358520
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic effect of hemin in colonic epithelial cell line: involvement of 18 kDa translocator protein (TSPO).
Gemelli C; Dongmo BM; Ferrarini F; Grande A; Corsi L
Life Sci; 2014 Jun; 107(1-2):14-20. PubMed ID: 24792517
[TBL] [Abstract][Full Text] [Related]
10. PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO).
Tu LN; Zhao AH; Stocco DM; Selvaraj V
Endocrinology; 2015 Mar; 156(3):1033-9. PubMed ID: 25535830
[TBL] [Abstract][Full Text] [Related]
11. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S
Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988
[TBL] [Abstract][Full Text] [Related]
12. Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Wen QL; Yi HQ; Yang K; Yin CT; Yin WJ; Xiang FY; Bao M; Shuai J; Song YW; Ge MH; Zhu X
Mol Cell Endocrinol; 2021 Mar; 523():111144. PubMed ID: 33383107
[TBL] [Abstract][Full Text] [Related]
13. [TSPO ligand PK11195 and MAPK inhibitor UO126 modulate tspo expression level].
Gyrylova SN; Ruksha TG; Komina AV
Tsitologiia; 2013; 55(2):131-5. PubMed ID: 23718075
[TBL] [Abstract][Full Text] [Related]
14. Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine.
Kugler W; Veenman L; Shandalov Y; Leschiner S; Spanier I; Lakomek M; Gavish M
Cell Oncol; 2008; 30(5):435-50. PubMed ID: 18791274
[TBL] [Abstract][Full Text] [Related]
15. RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function.
Rahbari R; Kitano M; Zhang L; Bommareddi S; Kebebew E
J Clin Endocrinol Metab; 2013 Mar; 98(3):E446-54. PubMed ID: 23393170
[TBL] [Abstract][Full Text] [Related]
16. The effects of PK11195 on the MCF-7 and T47D were associated with the allopregnanolone biosynthesis, which was mediated by Translocator Protein 18 KDa.
Xu JN; Shen D; Mao WD; Lin QF; Lin F; Lu C
Cancer Biomark; 2016 Apr; 17(1):11-6. PubMed ID: 27062569
[TBL] [Abstract][Full Text] [Related]
17. The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines.
Mendonça-Torres MC; Roberts SS
Cancer Biol Ther; 2013 Apr; 14(4):319-26. PubMed ID: 23358477
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological suppression of the Ras/MAPK pathway in thyroid carcinoma cells can provoke opposite effects on cell migration and proliferation: The appearance of yin-yang effects and the need of combinatorial treatments.
Glassmann A; Winter J; Kraus D; Veit N; Probstmeier R
Int J Oncol; 2014 Dec; 45(6):2587-95. PubMed ID: 25269412
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
20. Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.
Ostuni MA; Ducroc R; Péranzi G; Tonon MC; Papadopoulos V; Lacapere JJ
Biol Cell; 2007 Nov; 99(11):639-47. PubMed ID: 17561806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
